Stimulant drugs

European Child and Adolescent Psychiatry

Volumn 9, Issue SUPPL. 1, 2000, Pages

  Santosh, P J ^a   Taylor, E ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Adderall; ADHD; Dexamphetamine; Guidelines; Methylphenidate; Pemol ine; Pharmacotherapy; Stimulants

Indexed keywords

AMPHETAMINE; DEXAMPHETAMINE; METHYLPHENIDATE; PEMOLINE;

ABDOMINAL PAIN; APPETITE DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; DRUG EFFECT; DRUG EFFICACY; DYSPHORIA; HEADACHE; HUMAN; INSOMNIA; INTRINSIC SYMPATHOMIMETIC ACTIVITY; IRRITABILITY; PRACTICE GUIDELINE; PRESCRIPTION; TREATMENT INDICATION;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD PSYCHIATRY; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; COST-BENEFIT ANALYSIS; DRUG COSTS; DRUG THERAPY, COMBINATION; EATING DISORDERS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; PRACTICE GUIDELINES; PSYCHOTHERAPY;

EID: 0033667221     PISSN: 10188827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007870070017     Document Type: Article

References (111)

1. Neurotransmitter transporters: Recent progress
2. Practice parameters for the assessment and treatment of children, adolescents and adults with attention-deficit/hyperactivity disorder
3. Psychiatric sequelae of amphetamine use
4. Sustained release methylphenidate
5. National Institute of Mental Health Collaborative Multimodal Treatment Study Of Children With ADHD the (MTA): Design challenges and choices
6. Treatment of children with Williams syndrome with methylphenidate
7. Pemoline-associated fulminant liver failure: Testing the evidence for causation
8. Pharmacotherapy of attention deficit-hyperactivity disorder reduces risk for substance use disorder
9. Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter
10. The behaviour of children receiving benzedrine
11. An in-flight investigation of the efficacy of dextroamphetamine for sustaining helicopter pilot performance
12. Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: Effects of stimulant and dose
13. Response to methylphenidate in children with ADHD and comorbid anxiety
14. Dose effects and individual responsivity to methylphenidate in attention deficit disorder
15. Experimental studies on the long-term effects of methylphenidate hydrocloride
16. Response of children with ADHD to methylphenidate: Interaction with internalizing symptoms
17. Methylphenidate and dextroamphetamine treatments of hyperactivity: Are there true non-responders?
18. Effects of sustained-release and standard preparations of methylphenidate on attention deficit disorder
19. Treatment modalities for narcolepsy
20. Long-term methylphenidate therapy in children with c omorbid ADHD and chronic multiple tic disorder
21. Role of seratonin in the paradoxical claiming effect of psychostimulants on hyperactivity
22. Methylphenidate treatment of negative symptoms in patients with dementia
23. Tranylcypromine in narcolepsy
24. Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms: A randomized double-blind placebo-controlled trial
25. Comparative effects of methylphenidate and thioridazine in hyperkinetic children. I. Clinical results
26. Diagnosis and treatment of attention-deficit/hyperactivity disorder
27. Medication treatment strategies in the MTA: Relevance to clinicians and researchers
28. Psychostimulants
29. Stimulant medication
30. Suspected adverse methylphenidate-imipramine interactions in children
31. Epilepsy and attention deficit hyperactivity disorder: Is methylphenidate safe and effective?
32. Attention deficit disorder in adults
33. Stimulant treatment for the neurobehavioural sequelae of traumatic brain injury
34. Psychostimulants in HIV-infected children and adolescents: A case series
35. Multimodel treatment plus stimulants vs stimulant treatment in ADHD children: Results from a two year comparative treatment study
36. Attention deficit hyperactivity disorder. CNS stimulants and sport
37. A comparative analysis of antidepressants and stimulants for the treatment of adults with ADHD
38. The use of methylphenidate in pediatric traumatic brain injury
39. The therapeutic effect of clonidine in attention deficit disorder with hyperactivity: A comparison with placebo and methylphenidate
40. Are stimulants over-prescribed? Treatment of ADHD in four US communities
41. FOCUS on the use of stimulants in children with attention deficit hyperactivity disorder
42. Hyperactivity and diet treatment: A meta-analysis of the Feingold hypothesis
43. Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder
44. Methylphenidate and behavioural modification in children with ADHD and comorbid ODD or CD: Main and incremental effects across settings
45. Depression and stimulant dependence: Neurobiology and pharmacotherapy
46. Fatigue therapy in multiple sclerosis: Results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo
47. Predictors of clonidine response in Tourette syndrome: Implications and inferences
48. Methamphetamine and driving impairment
49. Methylphenidate in terminal depression
50. Psychopharmacologic treatment of acquired attention disorders in children with brain injury
51. Differential effectiveness of methylphenidate and Adderall in school-age youths with attention deficit/hyperactivity disorder
52. Use of stimulants in the medically ill
53. Selegeline hydrochloride treatment in narcolepsy. A double-blind, placebo-controlled study
54. Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain
55. Moderators and mediators of treatment response for children with attention deficit/hyperactivity disorder
56. Fourteen-month randomized clinical trial of treatment strategies for attention deficit/ hyperactivity disorder
57. Effects of methylphenidate on preschool children with ADHD: Cognitive and behavioural functions
58. Dopaminergic agents and stimulants as antidepressant augmentation strategies
59. Principles for treating hyperkinetic disorder: Practice approaches for the UK
60. Pharmokinetics and actions of methylphenidate
61. Relative efficacy of long-acting stimulants on ADHD children: A comparison of standard methylphenidate, Ritalin-SR, Dexedrine spansule, and pemoline
62. Individual differences in response to Ritalin in classwork and social behavior
63. Sustained release methylphenidate and standard methylphenidate; effects on cognitive and social behaviour in children with attention deficit disorder
64. A comparison of Ritalin and Adderall: Efficacy and time-course in children with attention deficit/ hyperactivity disorder
65. Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: A preliminary double-blind placebo-controlled study
66. Comorbidity of attention-deficit hyperactivity disorder and overanxious disorder
67. Effect of anxiety on cognition behaviour and stimulant response in ADHD
68. Dextroamphetamine: Cognitive and behavioural effects in normal and hyperactive boys and normal men
69. Attention deficit hyperactivity disorder and methylphenidate: The relationship between gross body weight and drug response in children
70. NIMH collaborative multisite multimodal treatment study of children with ADHD: I. Background and rationale
71. National trends in the prevalence of attention deficit/hyperactivity disorder and prescribing of methylphenidate among school-age children: 1990-1995
72. Absence of tolerance to the behavioural effects of methylphenidate and inattentive children
73. Is Ritalin an abused drug? Does it meet the criteria for a Schedule II substance?
74. Stimulants in the treatment of depression: A critical overview
75. Behavioural, situational, and temporal effects of treatment of ADHD with methylphenidate
76. Pharmacotherapy of ADHD
77. Methylphenidate treatment for bulemia nervosa associated with a cluster B personality disorder
78. Effects of methylphenidate and behavioural contingencies on sustained attention in ADHD: A test of the reward dysfunction hypothesis
79. Neuropsychopharmacological mechanisms of stimulant drug action in attention deficit hyperactivity disorder: A review and integration
80. A double-blind controlled study of methylphenidate treatment in closed head injury
81. Pharmacotherapy of attention-deficit disorder across the life-cycle
82. Growth deficits in ADHD children revisited: Evidence for disorder-associated growth delays?
83. Effect of stimulant medication on children with attention deficit disorder: A 'review of reviews'
84. Clonidine in the treatment of ADHD: Questions about safety and efficacy. Letter to the Editor
85. Analeg classroom assessment of Adderall in children with ADHD
86. Combining methylphenidate and clonidine: III-advised
87. Differential effects of MPG on working memory in ADHD children with and without comorbid anxiety
88. Methylphenidate and cognitive flexibility: Dissociated dose effects in hyperactive children
89. Comparison of inhibition of monoamine uptake by cocaine, methylphenidate and amphetamine
90. Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour
91. Syndromes of attention deficit and overactivit
92. Guidelines for treatment of hyperkinetic disorders
93. Medication and hyperactivity; a meta-analysis
94. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy
95. Selective effects of methylphenidate in attention deficit hyperactivity disorder: A functional magnetic resonance study
96. Sustained-release methylphenidate for cognitive impairment in HIV-1-infected drug abusers: A pilot study
97. Attention deficit hyperactivity disorder: Anxiety phenomena in children treated with psychostimulant medication for 6 months or more
98. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate
99. Dextroamphetamine as a treatment for depression and low energy in AIDS patients: A pilot study
100. Psychostimulants in psychiatry
101. Does stimulant medication improve the peer status of hyperactive children?
102. Comparison of sustained release methylphenidate in the treatment of minimal brain dysfunction
103. Effects of methylphenidate on attentional function after traumatic brain injury. A randomized, placebo-controlled trial
104. Controlled trial of high doses of pemoline for adults with attention deficit/hyperactivity disorder
105. Combining methylphenidate and clonidine: A clinically sound medication option
106. Childhood narcolepsy
107. Methylphenidate and seizure frequency in brain injured patients with seizure disorders